"B cell non Hodgkin lymphoma" trang 1 - tải miễn phí từ tailieunhanh
Clinical and prognostic features of non hodgkin lymphoma and preliminary effective evaluation of R-chop regimen in patients with diffuse large B-cell lymphoma

Clinical and prognostic features of non hodgkin lymphoma and preliminary effective evaluation of R-chop regimen in patients with diffuse large B-cell lymphoma
8    65    1
A study of pathological characteristics of pediatric non-Hodgkin lymphoma based on 2008 version of the world health organization classification of lymphoid neoplasms at children’s hospital 1

A study of pathological characteristics of pediatric non-Hodgkin lymphoma based on 2008 version of the world health organization classification of lymphoid neoplasms at children’s hospital 1
7    97    0
Investigation of histopathological and immunohistochemical features of patients with non hodgkin lymphoma

Investigation of histopathological and immunohistochemical features of patients with non hodgkin lymphoma
7    43    1
Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma

Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma
8    112    0
Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring

Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring
14    42    1
P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma

P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma
12    68    1
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)
11    38    1
Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature

Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature
6    87    0
Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma

Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma
9    100    0
Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens

Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens
9    57    3
Multiple secondary cauda equina non Hodgkin’s lymphoma: A case report and literature review

Multiple secondary cauda equina non Hodgkin’s lymphoma: A case report and literature review
5    86    0
Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis
10    71    1
Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis
11    47    1
Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis

Prognostic significance of pretreatment serum free fatty acid in patients with diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis
9    61    1
TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP
7    61    1
Whole exome sequencing of microdissected splenic marginal zone lymphoma: A study to discover novel tumor-specific mutations

Whole exome sequencing of microdissected splenic marginal zone lymphoma: A study to discover novel tumor-specific mutations
10    40    1
The PI3K/AKT/mTOR signalling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis

The PI3K/AKT/mTOR signalling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis
11    22    1
Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation

Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation
13    97    1
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: Long-term results from a single center in China

Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: Long-term results from a single center in China
11    39    1
báo cáo khoa học:

báo cáo khoa học: " Cardiac tamponade and paroxysmal third-degree atrioventricular block revealing a primary cardiac non-Hodgkin large B-cell lymphoma of the right ventricle: a case report"
5    81    0